Atomoxetine in abstinent cocaine users: Sex differences
Data presented are from a sex-differences secondary analysis of a human laboratory investigation of single doses of atomoxetine (40 mg and 80 mg) versus placebo in abstinent individuals with cocaine use disorders (CUD). Subjective drug effects, cognitive performance and cardiovascular measures were...
Main Authors: | Elise E. DeVito, Aryeh I. Herman, Noah S. Konkus, Huiping Zhang, Mehmet Sofuoglu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-10-01
|
Series: | Data in Brief |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340917303888 |
Similar Items
-
Sex-based differences in multidimensional clinical assessments of early-abstinence crack cocaine users.
by: Breno Sanvicente-Vieira, et al.
Published: (2019-01-01) -
Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings
by: MARIA ePEDRAZ, et al.
Published: (2015-02-01) -
Sex differences in brain regional homogeneity during acute abstinence in cocaine use disorder
by: Buchweitz, A., et al.
Published: (2022) -
The Efficacy of Contingency Management on Cocaine Craving, using Prize-based Reinforcement of Abstinence in Cocaine Users
by: Bijan Pirnia, et al.
Published: (2016-11-01) -
Cocaine and Sleep: Early Abstinence
by: Peter T. Morgan, et al.
Published: (2007-01-01)